OxyMem
Rethinking Aeration - MABR Enables Efficient and Sustainable Wastewater Treatment Plant Expansions and Upgrades.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
N/A | Acquisition | ||
| Total Funding | 000k | ||
| EUR | 2016 | 2017 | 2020 | 2021 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 100 % | - | 161 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (558 %) | (280 %) | (722 %) | (279 %) |
| Profit | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (552 %) | (280 %) | (679 %) | (275 %) |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
OxyMem solves energy intensive wastewater treatment with an innovative ‘Drop in’ solution for wastewater aeration, the Membrane Aerated Biofilm Reactor (MABR). OxyMem MABR complements existing treatment systems and delivers up to 50% additional biological capacity (Incrementally) in an existing aeration or alternatively enables you to replace a legacy system.
Conventional wastewater treatment consumes 2-3% of a nation’s electricity production. This is due a 100 years reliance on bubble diffusion for conventional treatment plants which will typically suffer energy losses of 65-70% in the process because of the oxygen transfer limitations in the process. OxyMem does not have any such limitations.
OxyMem uses hollow fibre gas permeable membranes to support a fixed film ecosystem for the biology which allows for direct delivery of oxygen to the micro-organisms. OxyMem can achieve 95% oxygen transfer rates which results in superior energy performance (75% saving), lower sludge production (50% less sludge), along with impressive process resilience.